THE SHARE: Change: 0.00 SEK (-2.10%) / Price: 0.16 SEK / Oct 10, 2025, 6:00 pm (CEST)
  • Home
  • About
    • Introduction
    • Board of Directors
    • Management Team
    • Medical Advisors
    • Corporate Governance
    • Career
  • Technology
    • Physiological Targeting
    • Functional Nanoparticles
    • Publications
    • Patent
  • Portfolio
    • Pipeline
    • SpagoPix
    • Tumorad
  • Investor Relations
    • The Share
    • Analyst Coverage
    • Owners
    • Financial Reports
    • Financial Calendar
    • Equity research
    • Shareholder’s Personal Data
    • Share Issue
  • Media
    • Spago Nanomedical in media
    • Press Releases
    • Subscribe
    • Presentations
    • Events
    • Image Bank
  • Contact
    • Contact us

Spago Nanomedical in media

  • 12 Mar, 2010
    New Head of Business Development
  • 20 Nov, 2009
    Professor Sven Lidin joins the Scientific Advisory Board
  • 20 Oct, 2009
    Proof-of-Concept studies completed
  • 10 Oct, 2008
    New Senior Research Scientist
  • 23 Sep, 2008
    SPAGO signs agreement
  • 8 Jan, 2008
    Move to new labs
  • 7 Sep, 2007
    New CTO
  • 1
  • …
  • 17
  • 18
  • 19
  • Previous
Back
  • Spago Nanomedical in media
  • Press Releases
  • Subscribe
  • Presentations
  • Events
  • Image Bank

About Spago Nanomedical

Spago Nanomedical AB is a Swedish nanomedicines company in clinical development phase. The company´s development projects are based on a platform of polymeric materials with unique properties for more precise diagnosis and treatment of life-threatening and debilitating diseases.

Address

Spago Nanomedical AB
Scheelevägen 22
SE-223 63 Lund
Sweden

Contact

Phone: +46 46 811 88
LinkedIn

Member of:

Copyright © 2025 Spago Nanomedical AB. All Rights Reserved.
Design by Clavis Communications